Evidence map›Paper›PMID 38993729›Full record

ArticleDigital discovery2024

ProtAgents: protein discovery

Alireza Ghafarollahi, Markus J Buehler

Abstract read
In one paragraph

Article in Digital discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Controllable Protein Design by Prefix-Tuning Protein Language Models.Journal of chemical information and modeling · 2026
    Article
  8. Sustainable Materials Design With Multi-Modal Artificial Intelligence.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Peptide-based drug design using generative AI.Chemical communications (Cambridge, England) · 2026
    Review
  13. LLM-driven design of physics-constrained constitutive models: Two agents are better than one.Machine learning for computational science and engineering · 2026
    Article
  14. Article
  15. LIDDIA: Language-based Intelligent Drug Discovery Agent.Proceedings of the Conference on Empirical Methods in Natural Language Processing. Conference on Empirical Methods in Natural Language Processing · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alireza GhafarollahiLaboratory for Atomistic and Molecular Mechanics (LAMM), Massachusetts Institute of Technology 77 Massachusetts Ave. Cambridge MA 02139 USA mbuehler@MIT.EDU.
Markus J BuehlerLaboratory for Atomistic and Molecular Mechanics (LAMM), Massachusetts Institute of Technology 77 Massachusetts Ave. Cambridge MA 02139 USA mbuehler@MIT.EDU.ORCID https://orcid.org/0000-0002-4173-9659

Funding

Models to Predict Protein Biomaterial PerformanceU01EB014976 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI BUEHLER, MARKUS J., KAPLAN, DAVID L. · 2012 to 2020
$5.2M
Strain Analysis Software for Open ScienceR01AR077793 · NIAMS · WASHINGTON UNIVERSITY · PI Guy M Genin, Stavros Thomopoulos · 2020 to 2026
$5.2M
NIAMS NIH HHS R01 AR077793NIBIB NIH HHS U01 EB014976
6 · The paper itself

Abstract

Designing

Identifiers

PMID38993729
PMCPMC11235180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.